Investment in NovoDX, a Related Party (Details Narrative) - USD ($) |
12 Months Ended | |
|---|---|---|
May 14, 2024 |
Dec. 31, 2025 |
|
| Loss on investments | $ 500,000 | |
| Investments | $ 0 | |
| Novo DX Corporation [Member] | Common Stock [Member] | ||
| Restricted shares, price per share | $ 19.89 | |
| Novo DX Corporation [Member] | ||
| Number of restricted common stock purchased | 25,134 | |
| Value of restricted common stock purchased | $ 500,000 |
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|